Age-Related Macular Degeneration

>

The HCPLive age-related macular degeneration condition center page is a comprehensive resource for clinical news and insights on retina disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for patients with AMD.

Latest News

ONS-5010 for Wet AMD Fails to Meet Noninferiority in NORSE EIGHT Trial | Image Credit: Unsplash/Perchek Industries
ONS-5010 for Wet AMD Fails to Meet Noninferiority in NORSE EIGHT Trial

November 27th 2024

ONS-5010 missed the pre-specified non-inferiority endpoint set with the FDA, but Outlook Therapeutics plans to resubmit the BLA in Q1 of 2025.

LUNA, OPTIC Data Support Long-Term Benefit of Ixo-Vec for Wet AMD | Image Credit: Retina Consultants of Texas
LUNA, OPTIC Data Support Long-Term Benefit of Ixo-Vec for Wet AMD

November 24th 2024

Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status | Image Credit: Vitreo Retinal Associates
Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status

November 22nd 2024

FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy | Image Credit: US Food and Drug Administration
FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy

November 22nd 2024

Face Masking Did Not Affect Endophthalmitis Rates After Anti-VEGF Injections | Image Credit: Wills Eye Hospital
Face Masking Did Not Affect Endophthalmitis Rates After Anti-VEGF Injections

October 21st 2024

© 2024 MJH Life Sciences

All rights reserved.